DOD Releases Final Nine Awards for Distributed Bioindustrial Manufacturing Program
November 14, 2024
November 14, 2024
WASHINGTON, Nov. 14 -- The U.S. Department of Defense issued the following news:
The Department of Defense today announced the remaining nine awards to bioindustrial firms under the Distributed Bioindustrial Manufacturing Program (DBIMP). This announcement completes the first phase of DBIMP investment at 34 total awards worth over $60 million.
The awardees include Amyris, based in Emeryville, California; Cauldron Molecules, based in in Australia and the United States; C . . .
The Department of Defense today announced the remaining nine awards to bioindustrial firms under the Distributed Bioindustrial Manufacturing Program (DBIMP). This announcement completes the first phase of DBIMP investment at 34 total awards worth over $60 million.
The awardees include Amyris, based in Emeryville, California; Cauldron Molecules, based in in Australia and the United States; C . . .